Skip to main content

Cannabis sales grow in Israel

The Lod-based company Panaxia reported increased revenues from the Israeli market for its sales of medical cannabis in 2021.

Israel cannabis
A worker checks plants at a greenhouse of Israeli company B.O.L Pharma, which makes medical cannabis products, near Moshav Yad Binyamin in southern Israel on Feb. 1, 2022. — MENAHEM KAHANA/AFP via Getty Images

The Israeli cannabis company Panaxia released its earnings for 2021 Tuesday. 

Panaxia, which is based in the mixed Arab-Jewish city of Lod, said its net Israeli revenues increased 38% to $83.6 million, according to a press release. 

Panaxia also began exporting medical cannabis oils abroad in late 2020. Export revenues for 2020 and 2021 were $5.6 million, per the release. 

Panaxia’s stock increased by 0.45% today to 67.10 Israeli shekels ($20.94). 

SUBSCRIBER EXCLUSIVE

Continue reading this exclusive analysis

Original reporting and analysis unavailable elsewhere. Subscribe to AL-MONITOR to read this story and access everything we publish